TWM559175U - Acacia gerberate capsule structure - Google Patents

Acacia gerberate capsule structure Download PDF

Info

Publication number
TWM559175U
TWM559175U TW106215844U TW106215844U TWM559175U TW M559175 U TWM559175 U TW M559175U TW 106215844 U TW106215844 U TW 106215844U TW 106215844 U TW106215844 U TW 106215844U TW M559175 U TWM559175 U TW M559175U
Authority
TW
Taiwan
Prior art keywords
acacia
capsule
sustained release
release film
group
Prior art date
Application number
TW106215844U
Other languages
Chinese (zh)
Inventor
Sung-Chih Ting
Original Assignee
Ting Sung Chih
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ting Sung Chih filed Critical Ting Sung Chih
Priority to TW106215844U priority Critical patent/TWM559175U/en
Publication of TWM559175U publication Critical patent/TWM559175U/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

本創作係關於一種合歡香葉酯膠囊結構體,內容包含一膠囊體,所述膠囊體具有一緩釋膜層,所述緩釋膜層之內部設置有一容置空間,在該容置空間內有適量之合歡香葉酯混成結構體,其中該合歡香葉酯混成結構體,主成分包含五烯酯(Gefarnate),結合緩釋皮膜所製成之緩釋膜層密封,達成便利攜帶與胃黏膜保護及潰瘍癒合臨床服用的目的。 The present invention relates to a compound of acacia geranyl ester capsule, which comprises a capsule body, the capsule body having a sustained release film layer, and an inner space of the sustained release film layer is disposed in the accommodating space. There is an appropriate amount of acacia geranyl ester mixed structure, wherein the acacia geranyl ester mixed structure, the main component comprises pentagenyl ester (Gefarnate), combined with a sustained release film made of a sustained release film layer seal, to achieve convenient carrying and stomach Mucosal protection and ulcer healing for clinical purposes.

Description

一種合歡香葉酯膠囊結構體 Acacia geranyl ester capsule structure

本創作為一種合歡香葉酯膠囊結構體,尤指一種具有方便攜帶及服用優點與功效之合歡香葉酯膠囊產品,特別結合皮膜包覆技術形成具有胃黏膜保護及潰瘍癒合效果的合歡香葉酯膠囊配方並且方便吸收之產品。 The present invention is a compound of acacia geranyl ester capsule, especially a kind of acacia geranyl ester capsule product which has the advantages and functions of carrying and taking, and is specially combined with the film coating technology to form acacia fragrant leaves with gastric mucosal protection and ulcer healing effect. Formulated with an ester capsule and easily absorbed.

慢性胃炎是指各種病因引起的胃黏膜的慢性炎症性病變,多數是胃竇為主的胃炎,胃黏膜層以淋巴細胞和漿細胞浸潤為主,部分患者在後期可出現胃黏膜固有腺體萎縮。胃炎常反覆發作,中年以上好發病,並有隨年齡增長而發病率增加的傾向。慢性胃炎主要病因有幽門螺桿菌感染、免疫因素,十二指腸液、膽汁反流為常見的物理化學因素損傷,而且某些因素之間可能還有相加或協同損害作用。大多數慢性胃炎患者無明顯症狀,或有程度不同的消化不良的症狀,如以進餐後為重的上腹不適、飽脹、無規律的腹痛、反酸、噯氣、燒灼感、食慾減退、噁心、嘔吐等。少數伴有胃黏膜糜爛者有上消化道出血,雖然一般為少量出血。慢性胃體炎消化道症狀較少,可出現明顯厭食、體重減輕,伴有貧血。慢性胃炎大多無明顯體徵,有時可有上腹部輕壓痛。腸胃道用藥有許多, 針對使用效率及效能發揮,在習知技藝中特別以錠劑、液劑及針劑的使用特別常見。針劑的使用主要在提升吸收效率,解決錠劑、液劑吸收效率不佳的狀況。又隨著現代人對機能性保健產品或健康食品或藥品服用的功效、口感、氣味、品質需求越來越高,為了在現有市場上佔有一席之地,各機能性保健產品或健康食品或藥品業者即不斷研發新產品,以配合現代人求新求變之市場需求性,進而達到提昇市場競爭力的效果;緣是,本創作人有鑑於現有機能性保健產品或健康食品或藥品之需求,並針對服用方式、吸收方式、氣味避免、功效多樣性及攜帶便利性等問題加以解決,創作一種用於胃黏膜保護及潰瘍癒合之合歡香葉酯膠囊結構體,提供一種服用及攜帶方便、並對於腸胃道潰瘍及保護具有功效的合歡香葉酯膠囊結構體,大大創造並提升使用領域及功能,顛覆習知技藝對腸胃用功能產品的限制。本創作提供一種用於胃黏膜保護及潰瘍癒合之合歡香葉酯膠囊結構體軟膠囊是繼片劑,針劑之後發展起來的一種新劑型,其外殼是用明膠壓制而成,囊殼內包液狀藥液。其特點是比針劑起效慢,但又比片劑,膠囊,顆粒劑起效快。生物利用度高,比口服液攜帶方便,又可在囊殼上稍加改變,便可做成腸溶軟膠囊等緩釋劑型,還可做成栓劑。由於軟膠囊劑具有其它劑型所不具備的含量精確,工藝科學,使用方便,生物利用度高,起效快,療效高等優點。而越來越受到市場和患者的青睞。 Chronic gastritis refers to chronic inflammatory lesions of gastric mucosa caused by various causes, most of which are gastric antrum-based gastritis. The gastric mucosa is mainly infiltrated by lymphocytes and plasma cells. Some patients may have gastric glandular glandular atrophy in the later stage. . Gastritis often recurs, with a good onset in middle age and above, and a tendency to increase with age. The main causes of chronic gastritis include Helicobacter pylori infection and immune factors. Duodenal juice and bile reflux are common physical and chemical factors, and some factors may have additive or synergistic damage. Most patients with chronic gastritis have no obvious symptoms, or have different degrees of dyspepsia, such as upper abdominal discomfort after eating, fullness, irregular abdominal pain, acid reflux, belching, burning sensation, loss of appetite, nausea, Vomiting and so on. A small number of people with gastric mucosal erosion have upper gastrointestinal bleeding, although usually a small amount of bleeding. Chronic gastritis has fewer gastrointestinal symptoms and can cause significant anorexia, weight loss, and anemia. Most of the chronic gastritis has no obvious signs, and sometimes there may be mild tenderness in the upper abdomen. There are many drugs in the gastrointestinal tract. In particular, the use of lozenges, liquids, and injections is particularly common in conventional techniques for use efficiency and efficacy. The use of the injection mainly improves the absorption efficiency and solves the problem that the absorption efficiency of the tablet and the liquid agent is not good. With the increasing demand for efficacy, taste, smell and quality of modern people's functional health care products or health foods or medicines, in order to have a place in the existing market, each functional health care product or health food or pharmaceutical industry is Continuously research and develop new products to meet the market demand of modern people seeking new changes, and thus achieve the effect of enhancing market competitiveness; the reason is that the creators have in view of the needs of existing functional health products or health foods or medicines, and The method of taking, absorbing, odor avoiding, diversifying efficacy and carrying convenience solves the problem, creating a compound of acacia geranyl ester capsule for gastric mucosal protection and ulcer healing, providing a convenient and convenient for taking and carrying The ulcer and the protective acacia geranyl ester capsule structure greatly create and enhance the field of use and function, and subvert the limitations of conventional techniques on functional products for the gastrointestinal tract. The present invention provides a soft capsule of acacia geranyl ester capsule structure for gastric mucosal protection and ulcer healing. It is a new dosage form developed after tablets and injections, and the outer shell is made of gelatin, and the capsule is filled with liquid. Liquid medicine. It is characterized by slower onset than injections, but it works faster than tablets, capsules and granules. It has high bioavailability, is convenient to carry than oral liquid, and can be changed slightly on the capsule shell to make a sustained release dosage form such as enteric soft capsules, and can also be used as a suppository. Because soft capsules have the precise content, scientific process, convenient use, high bioavailability, fast onset and high curative effect that other dosage forms do not have. It is increasingly favored by the market and patients.

本創作係關於一種用於胃黏膜保護及潰瘍癒合之合歡香葉酯膠囊結構體,本創作之第一特色,在於臨床研究證實合歡香葉酯膠囊結構體具有 可增加消化管黏膜組織之血流量及黏液分泌作用,並可使黏液層厚度增加而強化組織之抵抗性,還可以增強胃黏液障蔽(GASTRIC MUCOUS BARRIER)作用,可強化黏膜組織。本創作之第二特色,在於臨床研究證實合歡香葉酯膠囊結構體具有可活化潰瘍部分之組織代謝,增加組織修復能力,促進上皮細胞的新生及機能回復,使受損之黏膜組織痊癒。本創作之第三特色,在於臨床研究證實合歡香葉酯膠囊結構體可增強黏膜組織的抵抗作用,而且面對潰瘍的再發有抑制之功效。本創作之第四特色,在於合歡香葉酯膠囊結構體可抵抗酸環境到腸道才進行內容物的釋放,增加黏膜吸收的效率,並迅速發揮藥理功效。本創作之第五特色,在於合歡香葉酯膠囊結構體,具有方便使用者直接食用,以及具有攜帶便利性之優點。本創作係關於一種用於胃黏膜保護及潰瘍癒合之合歡香葉酯膠囊結構體,包含有:一膠囊體,所述膠囊體具有一緩釋膜層,所述緩釋膜層之內部設置有一容置空間,在該容置空間內有適量之合歡香葉酯混成結構體,其中該緩釋膜層可將該合歡香葉酯混成結構體密封於該容置空間內。 This creation is about a compound of Acacia fragrans capsule for gastric mucosal protection and ulcer healing. The first feature of this creation is that clinical studies have confirmed that the Acacia geranium capsule structure has It can increase the blood flow and mucus secretion of the digestive tract mucosa, and increase the thickness of the mucus layer to enhance the resistance of the tissue. It can also enhance the action of the gastric mucus barrier (GASTRIC MUCOUS BARRIER) and strengthen the mucosal tissue. The second characteristic of this creation is that clinical studies have confirmed that the structure of the acacia geranyl ester capsule has the tissue metabolism of the activated ulcer part, increases the tissue repair ability, promotes the regeneration and function recovery of the epithelial cells, and cures the damaged mucosa tissue. The third characteristic of this creation is that clinical studies have confirmed that the structure of the acacia geranyl ester capsule can enhance the resistance of the mucosal tissue and inhibit the recurrence of the ulcer. The fourth characteristic of this creation is that the structure of the acacia geranyl ester capsule can resist the release of the contents from the acid environment to the intestine, increase the efficiency of mucosal absorption, and rapidly exert pharmacological effects. The fifth feature of the creation is the acacia geranyl ester capsule structure, which has the advantages of convenient consumption by the user and convenience of carrying. The present invention relates to a compound of acacia geranyl ester capsule for gastric mucosal protection and ulcer healing, comprising: a capsule body having a sustained release film layer, wherein the sustained release film layer is internally provided with a capsule body The accommodating space has an appropriate amount of acacia sinensis mixed structure in the accommodating space, wherein the sustained-release film layer seals the acacia sinensis mixed structure into the accommodating space.

優選地,該合歡香葉酯混成結構體具有一選自由凝膠、顆粒懸浮液、均勻液、乳化液所組成族群之組合的外觀型態,且該膠囊體為一種具有液態密合性之膠囊體。 Preferably, the acacia sinensis mixed structure has an appearance selected from the group consisting of a gel, a particle suspension, a homogeneous liquid, and an emulsion, and the capsule body is a capsule having liquid adhesion. body.

優選地,該合歡香葉酯混成結構體具有一選自由粉末、片材、包覆體、黏附體所組成族群之組合的外觀型態,且該膠囊體為一種具有固態密合性之膠囊體。 Preferably, the acacia sinensis mixed structure has an appearance selected from a combination of a group consisting of a powder, a sheet, an envelope, and an adherent, and the capsule body is a capsule body having a solid adhesion. .

優選地,該合歡香葉酯混成結構體係透過合歡香葉酯與一輔料混成來達成,所述輔料係選自由植物油,芳香烴酯類,有機酸,甘油,異丙醇, 丙二醇,聚乙二醇(PEG),聚乙二醇400,脂肪酸甘油酯,中級脂肪酸甘油酯,表面活性劑,吐溫-80及其所組成之族群。 Preferably, the acacia geranyl ester mixed structure system is achieved by mixing acacia geranyl ester with an auxiliary material selected from the group consisting of vegetable oils, aromatic hydrocarbon esters, organic acids, glycerin, and isopropyl alcohol. Propylene glycol, polyethylene glycol (PEG), polyethylene glycol 400, fatty acid glycerides, intermediate fatty acid glycerides, surfactants, Tween-80 and its constituents.

優選地,該緩釋膜層與該容置空間之間,進一步包含一保護殼體,係透過一第一殼體及一第二殼體,共同對接組合形成,該保護殼體可緩衝密封該容置空間。 Preferably, the sustained-release film layer and the accommodating space further comprise a protective casing formed by a first butt joint and a second casing, and the protective casing can cushion the seal. Accommodate space.

優選地,該緩釋膜層係透過一選自皮膜密封方式,浸潤乾燥方式,包覆沉澱方式及其組合之族群來達成。 Preferably, the sustained release film layer is achieved by a group selected from the group consisting of a film sealing method, an infiltration drying method, a coating precipitation method, and a combination thereof.

優選地,該緩釋膜層係透過一選自厚牛明膠皮膜,牛明膠皮膜,魚明膠皮膜,豬明膠皮膜,禽明膠皮膜,卡拉膠海藻萃取皮膜,非明膠皮膜及其組合所組成之族群來達成。更優選地,該緩釋膜層係透過一選自由卡拉膠海藻萃取皮膜,非明膠皮膜及其組合所組成之族群來達成。 Preferably, the sustained release film layer is passed through a group selected from the group consisting of thick bovine gelatin film, bovine gelatin film, fish gelatin film, pig gelatin film, poultry gelatin film, carrageenan seaweed extract film, non-gelatin film and combinations thereof. To reach. More preferably, the sustained release film layer is achieved by a population selected from the group consisting of a carrageenan extract film, a non-gelatin film, and combinations thereof.

優選地,該緩釋膜層具有一選自由圓形,橢圓形,魚形,管形及其組合之形狀。 Preferably, the sustained release film layer has a shape selected from the group consisting of a circle, an ellipse, a fish, a tube, and a combination thereof.

本創作提供一種用於胃黏膜保護及潰瘍癒合之合歡香葉酯膠囊結構體包含一具有容納空間之膠囊體;以及置於該容器之內部空間,內有適量之一合歡香葉酯混成結構體,並利用機能性合歡香葉酯混成結構體所含物質質量百分比的的組合變化,以適用於醫藥品或健康食品或保健產品。由於本創作設計具有腸胃道生理機能改善、胃黏膜保護及潰瘍癒合功效之機能性合歡香葉酯混成結構體包裝於一膠囊體內,因此只需服用一種膠囊體便可同時達成預期機能性功效,並具有方便攜帶及服用及多功效之優點。 The present invention provides a compound of acacia geranyl ester capsule for gastric mucosal protection and ulcer healing, comprising a capsule body having a receiving space; and an inner space of the container, having an appropriate amount of acacia geranium mixed structure And using a combined change in the percentage of the mass of the substance contained in the functional acacia geranium-mixed structure to be suitable for use in pharmaceuticals or health foods or health care products. Because of the functional design of the gastrointestinal physiology improvement, gastric mucosal protection and ulcer healing function, the functional acacia geranyl ester mixed structure is packaged in a capsule body, so that only one capsule body can achieve the desired functional effect at the same time. It has the advantages of being easy to carry and take and more effective.

1,1’‧‧‧膠囊體 1,1’‧‧‧ capsule body

3,3’‧‧‧合歡香葉酯混成結構體 3,3'‧‧‧Acacia geranyl ester mixed structure

11‧‧‧第一殼體 11‧‧‧First housing

12‧‧‧第二殼體 12‧‧‧ second housing

13,13’‧‧‧容置空間 13,13’‧‧‧ accommodating space

15,15’‧‧‧緩釋膜層 15,15'‧‧‧ sustained release film

第1圖:係為本創作第一實施例之合歡香葉酯膠囊結構體示意圖。 Fig. 1 is a schematic view showing the structure of acacia geranyl ester capsule of the first embodiment of the present invention.

第2圖:係為本創作第二實施例之合歡香葉酯膠囊結構體示意圖。 Fig. 2 is a schematic view showing the structure of acacia geranyl ester capsule of the second embodiment of the present invention.

為讓本創作之上述及其他目的、特徵及優點能更明顯易懂,下文特舉本創作之較佳實施例,並配合所附圖式,作詳細說明如下: In order to make the above and other objects, features and advantages of the present invention more comprehensible, the preferred embodiments of the present invention are described in detail below with reference to the accompanying drawings.

第一實施例:一種合歡香葉酯膠囊結構體 First Embodiment: Acacia geranyl ester capsule structure

本創作提供用於胃黏膜保護及潰瘍癒合之合歡香葉酯膠囊結構體第一實施例,如第1圖所示,內容包含一膠囊體1,係由一第一殼體11及一第二殼體12所共同對接組合而成,並於該第一殼體11及該第二殼體12之內部形成有一容置空間13,在該容置空間13內有適量之合歡香葉酯混成結構體3,其中:該膠囊體1係由可食用等級之膠質原料製成;該合歡香葉酯混成結構體3主要為以合歡香葉酯為主的混成結構體,主成分合歡香葉酯是一種五烯酯(Gefarnate),IUPAC正式名稱[(2E)-3,7-dimethylocta-2,6-dienyl](4E,8E)-5,9,13-trimethyltetradeca-4,8,12-trienoate。透過本創作之技術與設計可得到機能性合歡香葉酯膠囊結構體,具有可直接食用而達到提高吸收性及便利性之功效。本創作合歡香葉酯混成結構體,優選地需用適宜的液體輔料溶解或混合,常用的輔料有植物油、芳香烴酯類、有機酸、甘油、 異丙醇、丙二醇、聚乙二醇(PEG)400以、中級脂肪酸甘油酯、表面活性劑及吐溫-80等。加入表面活性劑或其他吸收促進劑后製成軟膠囊,其中的藥物是以分子狀態分散於油中,在體內油相因表面活性劑的作用,自發形成乳劑,經淋巴進入血液,不受首過效應的影響,因而產生較高的生物利用度。優選地,膠囊體進一步外部包覆具有一緩釋膜層15,特定地,該緩釋膜層15係透過皮膜密封方式或浸潤乾燥方式或包覆沉澱方式來達成。更優選地本創作使用厚牛明膠皮膜,可完全氣密封入,膠囊強度和膜遮段性高,內容物可長期保持穩定,本創作之明膠皮膜對氧遮段性超過聚乙烯膜30倍以上,對空氣中氧非常穩定,能防止空氣氧化吸濕等,選用厚牛明膠皮膜亦可提供考量豬原料來源消費者合適的選擇,選擇性地亦可選用選自厚牛明膠皮膜,牛明膠皮膜,魚明膠皮膜,豬明膠皮膜,禽明膠皮膜,卡拉膠海藻萃取皮膜,非明膠皮膜及其組合所組成之族群。 The present invention provides a first embodiment of a eucalyptus gum capsule structure for gastric mucosal protection and ulcer healing. As shown in FIG. 1, the content comprises a capsule body 1 which is composed of a first housing 11 and a second The housings 12 are integrally butt-joined together, and an accommodating space 13 is formed in the first housing 11 and the second housing 12, and an appropriate amount of acacia sinensis mixed structure is disposed in the accommodating space 13. Body 3, wherein: the capsule body 1 is made of an edible grade of a gelatinous raw material; the acacia geranyl ester mixed structure 3 is mainly a mixed structure mainly composed of acacia geranyl ester, and the main component of acacia geranyl ester is A pentaester (Gefarnate), the official name of IUPAC [(2E)-3,7-dimethylocta-2,6-dienyl](4E,8E)-5,9,13-trimethyltetradeca-4,8,12-trienoate. The functional Acacia geranyl ester capsule structure can be obtained through the technology and design of the present invention, and has the effect of being directly edible to improve absorption and convenience. The artificial acacia geranyl ester mixed structure preferably needs to be dissolved or mixed with a suitable liquid auxiliary material, and the commonly used auxiliary materials are vegetable oil, aromatic hydrocarbon ester, organic acid, glycerin, Isopropyl alcohol, propylene glycol, polyethylene glycol (PEG) 400, intermediate fatty acid glycerides, surfactants and Tween-80. A soft capsule is prepared by adding a surfactant or other absorption enhancer, wherein the drug is dispersed in the molecular state in the oil, and the oil phase spontaneously forms an emulsion in the oil phase due to the action of the surfactant, and enters the blood through the lymph. The effects of over-effects result in higher bioavailability. Preferably, the capsule body is further externally coated with a sustained release film layer 15, and specifically, the sustained release film layer 15 is achieved by a film sealing method or a wet drying method or a coating precipitation method. More preferably, the creation uses a thick cow gelatin film, which can be completely hermetically sealed, the capsule strength and the film are highly segmented, and the content can be kept stable for a long time. The gelatin film of the present invention is more than 30 times more than the polyethylene film. It is very stable to oxygen in the air and can prevent oxidation and moisture absorption of the air. The thick cow gelatin film can also provide a suitable choice for consumers who are considering the source of pig raw materials. Alternatively, it can also be selected from thick cow gelatin film and bovine gelatin film. , fish gelatin film, pig gelatin film, poultry gelatin film, carrageenan seaweed extract film, non-gelatin film and its combination of ethnic groups.

第二實施例:一種合歡香葉酯膠囊結構體 Second Embodiment: Acacia geranyl ester capsule structure

本創作提供用於胃黏膜保護及潰瘍癒合之合歡香葉酯膠囊結構體第二實施例,提供一種用於胃黏膜保護及潰瘍癒合之合歡香葉酯軟膠囊結構體如第2圖所示,內容包含一膠囊體1’,所述膠囊體1’具有一緩釋膜層15’,所述緩釋膜層15’之內部設置有一容置空間13’,在該容置空間13’內有適量之合歡香葉酯混成結構體3’,其中:該膠囊體1’係由可食用等級之膠質原料製成;該合歡香葉酯混成結構體3’主要為為主的混成結構體,主成分合歡香葉酯是一種五烯酯(Gefarnate),IUPAC正式名稱[(2E)-3,7-dimethylocta-2,6-dienyl] (4E,8E)-5,9,13-trimethyltetradeca-4,8,12-trienoate。透過本創作之技術與設計可得到機能性合歡香葉酯膠囊結構體,具有可直接食用而達到提高吸收性及便利性之功效。所述緩釋膜層15’,該緩釋膜層15’係透過皮膜密封方式或浸潤乾燥方式或包覆沉澱方式來達成,優選地直徑小於1公分球體。透過本創作之技術與設計可得到機能性合歡香葉酯膠囊結構體,具有可直接食用而達到提高吸收性及便利性之功效。優選地合歡香葉酯混成結構體需用適宜的液體輔料溶解或混合,常用的輔料有植物油、芳香烴酯類、有機酸、甘油、異丙醇、丙二醇、聚乙二醇(PEG)400、中級脂肪酸甘-油酯、表面活性劑以及吐溫-80等。加入表面活性劑或其他吸收促進劑后製成軟膠囊,其中的藥物是以分子狀態分散於油中,在體內油相因表面活性劑的作用,自發形成乳劑,經淋巴進入血液,不受首過效應的影響,因而產生較高的生物利用度。特定地,所述膠囊體1’該緩釋膜層15’係透過皮膜密封方式或浸潤乾燥方式或包覆沉澱方式來達成。更優選地本創作所述膠囊體1’該緩釋膜層15’選用一種軟膠囊(Soft Gel Capsule)包覆系統,特定地使用厚牛明膠皮膜,可完全氣密封入,膠囊強度和膜遮段性高,內容物可長期保持穩定,本創作之明膠皮膜對氧遮段性超過聚乙烯膜30倍以上,對空氣中氧非常穩定,能防止空氣氧化吸濕等,選用厚牛明膠皮膜亦可提供考量豬原料來源消費者合適的選擇,選擇性地亦可選用選自厚牛明膠皮膜,牛明膠皮膜,魚明膠皮膜,豬明膠皮膜,禽明膠皮膜,卡拉膠海藻萃取皮膜,非明膠皮膜及其組合所組成之族群。 The present invention provides a second embodiment of a cedar geranyl ester capsule structure for gastric mucosal protection and ulcer healing, and provides a soft capsule structure of acacia geranyl ester for gastric mucosal protection and ulcer healing, as shown in FIG. 2, The content includes a capsule body 1' having a sustained release film layer 15'. The inside of the sustained release film layer 15' is provided with an accommodating space 13', and the accommodating space 13' is provided in the accommodating space 13'. An appropriate amount of acacia geranyl ester mixed structure 3', wherein: the capsule body 1' is made of an edible grade of a gelatinous raw material; the acacia geranyl ester mixed structure 3' is mainly a main mixed structure, the main The ingredient, acacia geranyl ester, is a pentaenyl ester (Gefarnate), the official name of IUPAC [(2E)-3,7-dimethylocta-2,6-dienyl] (4E, 8E)-5,9,13-trimethyltetradeca-4,8,12-trienoate. The functional Acacia geranyl ester capsule structure can be obtained through the technology and design of the present invention, and has the effect of being directly edible to improve absorption and convenience. The sustained release film layer 15' is obtained by a film sealing method, a wet drying method or a coating precipitation method, and preferably has a diameter of less than 1 cm. The functional Acacia geranyl ester capsule structure can be obtained through the technology and design of the present invention, and has the effect of being directly edible to improve absorption and convenience. Preferably, the acacia geranyl ester mixed structure needs to be dissolved or mixed with a suitable liquid auxiliary material, and the commonly used auxiliary materials are vegetable oil, aromatic hydrocarbon ester, organic acid, glycerin, isopropanol, propylene glycol, polyethylene glycol (PEG) 400, Intermediate fatty acid glycerol ester, surfactant and Tween-80. A soft capsule is prepared by adding a surfactant or other absorption enhancer, wherein the drug is dispersed in the molecular state in the oil, and the oil phase spontaneously forms an emulsion in the oil phase due to the action of the surfactant, and enters the blood through the lymph. The effects of over-effects result in higher bioavailability. Specifically, the capsule body 1' of the sustained release film layer 15' is achieved by a film sealing method or a wet drying method or a coating precipitation method. More preferably, the capsule body 1' of the sustained release film layer 15' is selected from a Soft Gel Capsule coating system, specifically using a thick gelatin gel film, which can be completely hermetically sealed, and the capsule strength and film coverage. The segmentation is high, and the content can be kept stable for a long time. The gelatin film of the present invention has more than 30 times of oxygen shielding than the polyethylene film, and is very stable to oxygen in the air, and can prevent oxidation and moisture absorption of the air, and the thick cow gelatin film is also selected. It can provide a suitable choice for consumers considering the source of raw materials for pigs. Alternatively, it can be selected from thick beef gelatin film, bovine gelatin film, fish gelatin film, pig gelatin film, poultry gelatin film, carrageenan seaweed extract film, non-gelatin film. And the group formed by its combination.

選擇性地,本創作提供一種用於胃黏膜保護及潰瘍癒合之合歡香葉酯軟膠囊結構體,係透過軟膠囊劑或軟膠丸劑成型技術將合歡香葉酯包覆 來達成,本實施例主要是將合歡香葉酯分散於油類或對明膠物無溶解作用的非水溶性的液體或混懸液中,進一步封閉於膠囊殼中而成,其形狀有圓形,橢圓形,魚形,管形等。軟膠囊是繼片劑,針劑之後發展起來的一種新劑型,其外殼是用明膠壓制而成,囊殼內包液狀藥液。其特點是比針劑起效慢,但又比片劑,膠囊,顆粒劑起效快。生物利用度高,比口服液攜帶方便,又可在囊殼上稍加改變,便可做成腸溶軟膠囊等緩釋劑型,還可做成栓劑。由於軟膠囊劑具有其它劑型所不具備的含量精確,工藝科學,使用方便,生物利用度高,起效快,療效高等優點。而越來越受到市場和患者的青睞。本創作可將合歡香葉酯分散於液狀油性物,而直接封入膠囊,無需使用吸附,包結之類的添加劑,而且本創作軟膠囊油性物含量高達60%~85%(重量),而像包接物一般的含量在50%以下。 Optionally, the present invention provides a soft-capsule structure of acacia sinensis for gastric mucosal protection and ulcer healing, which is coated with acacia sinensis by soft capsule or soft gel forming technique. In this embodiment, the acacia geranyl ester is mainly dispersed in an oil or a water-insoluble liquid or suspension which does not dissolve the gelatin, and is further enclosed in a capsule shell, and has a circular shape. , oval, fish, tube, etc. Soft capsules are a new type of preparation developed after tablets and injections. The outer shell is made of gelatin, and the capsule is filled with liquid medicine. It is characterized by slower onset than injections, but it works faster than tablets, capsules and granules. It has high bioavailability, is convenient to carry than oral liquid, and can be changed slightly on the capsule shell to make a sustained release dosage form such as enteric soft capsules, and can also be used as a suppository. Because soft capsules have the precise content, scientific process, convenient use, high bioavailability, fast onset and high curative effect that other dosage forms do not have. It is increasingly favored by the market and patients. This creation can disperse the carnation geranyl ester in liquid oily substance and directly enclose it in the capsule, without using additives such as adsorption and inclusion, and the oil content of the soft capsule of the present invention is as high as 60% to 85% by weight, and The content of the package is generally less than 50%.

本創作提供一種用於胃黏膜保護及潰瘍癒合之合歡香葉酯膠囊結構體具有穩定度高之特徵:創作提供一種用於胃黏膜保護及潰瘍癒合之合歡香葉酯膠囊結構體透過結合軟膠囊結構而有遮光及避免氧化的作用,可減少有效成份接觸光線或空氣的機會。選擇性地,若用厚明膠制皮膜,可完全氣密封入,膠囊強度和膜遮斷性高,內容物可長期保持穩定。明膠皮膜對氧遮斷性超過聚乙烯膜30倍以上。對空氣中氧非常穩定,能防止空氣氧化吸濕等,穩定度高。本創作提供一種用於胃黏膜保護及潰瘍癒合之合歡香葉酯膠囊結構體歡香葉酯膠囊結構體具有劑量精準之特徵:利用高準確度的精密儀器,將有效成份均勻完全注入軟膠中,使量精準。本創作提供一種用於胃黏膜保護及潰瘍癒合之合歡香葉酯膠囊結構體歡香葉酯膠囊結構體具有好吸收之特徵:比傳統錠劑或硬膠囊的吸收度高,也比片劑,膠 囊,顆粒劑起效快,在胃液的酸鹼度中很容易溶解而使藥物很快釋出,所以人體更能有效利用。因而,使本創作可提供人體較高的生體可用率Better total bioavailability(AUC)、較快的吸收速率More rapid rate of absorption(tmax)、較高的血液濃度Higher blood levels(Cmax)。 The present invention provides a structure of acacia geranyl ester capsule for gastric mucosal protection and ulcer healing, which has the characteristics of high stability: the creation of a compound of acacia geranyl ester capsule for gastric mucosal protection and ulcer healing is combined with soft capsules. The structure is shaded and oxidized to reduce the chance of the active ingredient coming into contact with light or air. Alternatively, if a thick gelatin film is used, it can be completely hermetically sealed, and the capsule strength and film barrier property are high, and the contents can be kept stable for a long period of time. The gelatin film has an oxygen barrier property of more than 30 times that of the polyethylene film. It is very stable to oxygen in the air, prevents oxidation and moisture absorption of the air, and has high stability. The present invention provides a compound of acacia sinensis ester capsule for gastric mucosal protection and ulcer healing. The scented leaf ester capsule structure has the characteristics of precise dosage: the high-accuracy precision instrument is used to uniformly and completely inject the active ingredient into the soft rubber. To make the amount accurate. The present invention provides a compound of acacia geranyl ester capsule for gastric mucosal protection and ulcer healing. The fragrant leaf ester capsule structure has good absorption characteristics: higher absorption than traditional tablets or hard capsules, and also better than tablets. gum The granules and granules act quickly, and are easily dissolved in the pH of the gastric juice, so that the drug is released quickly, so the human body can be more effectively utilized. Therefore, the present invention can provide a higher total bioavailability (AUC), a faster rate of absorption (tmax), and a higher blood level (Cmax).

本創作提供一種用於胃黏膜保護及潰瘍癒合之合歡香葉酯膠囊結構體的其他特色:1.容易吞食:軟膠囊本身的明膠因遇水而溶解,能產生滑溜感,因此容易吞食。2.色香味俱全又便利:軟膠囊皮膜的味,色,香,透明度,光澤性均可自由選擇,與其他圓形物製品相比,外觀光澤好,引人注目。而且又讓使用者服用方便、攜帶容易,因此接受度高。3.能遮蓋某些內容物異臭,異味,不會像錠劑容易有異味殘留於口腔內。4.不需添加粘結劑,成型劑等添加劑,一般軟膠囊由明膠、甘油與水製成,系可食用天然製品。5.圓系氣密容器,製成後流通時異物不能混入,是一種凈化型容器。6.對於低沸點,揮發性物質如合歡香葉酯能穩定保存。而且有些禁忌配合成份可各自分別添加在二層性內容物內。 The present invention provides a special feature of acacia geranyl ester capsule structure for gastric mucosal protection and ulcer healing: 1. Easy to swallow: gelatin of the soft capsule itself dissolves due to water, and can produce a slippery sensation, so it is easy to swallow. 2. The color and flavor are both convenient and convenient: the taste, color, fragrance, transparency and gloss of the soft capsule film can be freely selected. Compared with other round products, the appearance is lustrous and eye-catching. Moreover, it is convenient for the user to take and easy to carry, so the degree of acceptance is high. 3. It can cover certain contents of odor, odor, and does not easily leave odor in the mouth like a tablet. 4. It is not necessary to add additives such as binders and molding agents. Generally, soft capsules are made of gelatin, glycerin and water, and are edible natural products. 5. A round-type airtight container is a purifying type container when foreign matter cannot be mixed in during circulation. 6. For low boiling points, volatile substances such as acacia sinensis can be stably stored. Moreover, some of the contraindication ingredients can be separately added to the two-layer content.

選擇性地,本創作提供一種用於胃黏膜保護及潰瘍癒合之合歡香葉酯膠囊結構體係使用非明膠皮膜,卡拉膠海藻萃取皮膜及其組合所組成置備而成之卡拉膠海藻萃取軟膠囊,透過強化使穩定性媲美明膠膠囊,以穩定保存內容成分。選擇性地,使本創作更具有特色,符合特定目標族群:1.適合素食者以及一般人使用;2.不含動物性原料3.堅固不易脆碎的特性更可以保護合歡香葉酯內容物;4.無基因改造生物原料。特定地卡拉膠海藻萃取軟膠囊是Vegesoft素食軟凝膠膠囊。 Optionally, the present invention provides a carrageenan seaweed extraction soft capsule prepared by using a non-gelatin film, a carrageenan seaweed extract film and a combination thereof for a gastric mucosal protection and ulcer healing. Stabilize the content of the ingredients by strengthening the gelatin capsules. Optionally, the creation is more distinctive and conforms to a specific target group: 1. suitable for vegetarians and ordinary people; 2. no animal raw materials 3. strong and brittle characteristics can protect the content of acacia geranyl ester; 4. No genetically modified biological materials. The specific carrageenan seaweed extract soft capsule is Vegesoft vegetarian soft gel capsule.

本案創作人從事生技醫療美容保養相關產品及生物醫藥工程材料開發 與研究經驗豐富,有鑑於此,本案創作人依其多年從事相關領域之研發經驗,針對前述之缺失進行深入探討,並依前述需求積極尋求解決之道,歷經長時間的努力研究與多次測試,終於完成此創作。雖然本創作已利用上述較佳實施例揭示,然其並非用以限定本創作,任何熟習此技藝者在不脫離本創作之精神和範圍之內,相對上述實施例進行各種更動與修改仍屬本創作所保護之技術範疇,因此本創作之保護範圍當視後附之申請專利範圍所界定者為準。 The creator of this case is engaged in the development of biotech medical beauty care related products and biomedical engineering materials. With such rich experience, in view of this, the creators of this case, based on their years of research and development experience in related fields, conducted in-depth discussions on the aforementioned shortcomings, and actively sought solutions based on the above-mentioned needs, after long-term efforts and multiple tests. And finally completed this creation. Although the present invention has been disclosed by the above-described preferred embodiments, it is not intended to limit the present invention, and it is still within the spirit and scope of the present invention to make various changes and modifications to the above embodiments. The technical scope of the protection is created, so the scope of protection of this creation is subject to the definition of the patent application scope attached.

Claims (9)

一種合歡香葉酯膠囊結構體,包含有:一膠囊體,所述膠囊體具有一緩釋膜層,所述緩釋膜層之內部設置有一容置空間,在該容置空間內有適量之合歡香葉酯混成結構體,其中該緩釋膜層可將該合歡香葉酯混成結構體密封於該容置空間內。 A comfrey geranyl ester capsule structure comprising: a capsule body having a sustained release film layer, wherein the sustained release film layer is provided with an accommodating space therein, and an appropriate amount is disposed in the accommodating space A compound of acacia geranium ester, wherein the sustained release film layer seals the mixed structure of acacia sinensis into the accommodating space. 如申請專利範圍第1項所述之合歡香葉酯膠囊結構體,其中該合歡香葉酯混成結構體具有一選自由凝膠、顆粒懸浮液、均勻液、乳化液所組成族群之組合的外觀型態,且該膠囊體為一種具有液態密合性之膠囊體。 The acacia geranyl ester capsule structure according to claim 1, wherein the acacia geranyl ester mixed structure has a appearance selected from the group consisting of a gel, a particle suspension, a homogeneous liquid, and an emulsion. And the capsule body is a capsule body having liquid adhesion. 如申請專利範圍第1項所述之合歡香葉酯膠囊結構體,其中該合歡香葉酯混成結構體具有一選自由粉末、片材、包覆體、黏附體所組成族群之組合的外觀型態,且該膠囊體為一種具有固態密合性之膠囊體。 The acacia geranyl ester capsule structure according to claim 1, wherein the acacia geranyl ester mixed structure has an appearance selected from the group consisting of powders, sheets, coatings, and adherends. And the capsule body is a capsule body having a solid adhesion. 如申請專利範圍第1項所述之合歡香葉酯膠囊結構體,其中該合歡香葉酯混成結構體係透過合歡香葉酯與一輔料混成來達成,所述輔料係選自由植物油,芳香烴酯類,有機酸,甘油,異丙醇,丙二醇,聚乙二醇(PEG),聚乙二醇400,脂肪酸甘油酯,中級脂肪酸甘油酯,表面活性劑,吐溫-80及其所組成之族群。 The acacia geranyl ester capsule structure according to claim 1, wherein the acacia geranyl ester mixed structure system is obtained by mixing acacia geranyl ester with an auxiliary material selected from the group consisting of vegetable oil and aromatic hydrocarbon ester. , organic acids, glycerol, isopropanol, propylene glycol, polyethylene glycol (PEG), polyethylene glycol 400, fatty acid glycerides, intermediate fatty acid glycerides, surfactants, Tween-80 and its constituents . 如申請專利範圍第1項所述之合歡香葉酯膠囊結構體,其中該緩釋膜層與該容置空間之間,進一步包含一保護殼體,係透過一第一殼體及一第二殼體,共同對接組合形成,該保護殼體可緩衝密封該容置空間。 The acacia geranium capsule structure according to claim 1, wherein the sustained release film layer and the accommodating space further comprise a protective casing through a first casing and a second The housing is formed by a common butt joint, and the protective housing can buffer and seal the accommodating space. 如申請專利範圍第1項所述之合歡香葉酯膠囊結構體,其中該緩釋膜層係透過一選自皮膜密封方式,浸潤乾燥方式,包覆沉澱方式及其組合之族群來達成。 The acacia geranol capsule structure according to claim 1, wherein the sustained release film layer is obtained by a group selected from the group consisting of a film sealing method, an infiltration drying method, a coating method, and a combination thereof. 如申請專利範圍第1項所述之合歡香葉酯膠囊結構體,其中該緩釋膜層係透過一選自由厚牛明膠皮膜,牛明膠皮膜,魚明膠皮膜,豬明膠皮膜,禽明膠皮膜,卡拉膠海藻萃取皮膜,非明膠皮膜及其組合所組成之族群來達成。 The acacia geranol capsule structure according to claim 1, wherein the sustained release film layer is selected from the group consisting of thick cow gelatin film, bovine gelatin film, fish gelatin film, pig gelatin film, poultry gelatin film, A group consisting of carrageenan seaweed extract membrane, non-gelatin membrane and combinations thereof. 如申請專利範圍第1項所述之合歡香葉酯膠囊結構體,其中該緩釋膜層具有一選自由圓形,橢圓形,魚形,管形及其組合之形狀。 The acacia sulphate capsule structure according to claim 1, wherein the sustained release film layer has a shape selected from the group consisting of a circle, an ellipse, a fish, a tube, and a combination thereof. 如申請專利範圍第7項所述之合歡香葉酯膠囊結構體,其中該緩釋膜層係透過一選自由卡拉膠海藻萃取皮膜,非明膠皮膜及其組合所組成之族群來達成。 The acacia sulphate capsule structure according to claim 7, wherein the sustained release film layer is obtained by a group selected from the group consisting of carrageenan seaweed extract film, non-gelatin film and combinations thereof.
TW106215844U 2017-10-26 2017-10-26 Acacia gerberate capsule structure TWM559175U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW106215844U TWM559175U (en) 2017-10-26 2017-10-26 Acacia gerberate capsule structure

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW106215844U TWM559175U (en) 2017-10-26 2017-10-26 Acacia gerberate capsule structure

Publications (1)

Publication Number Publication Date
TWM559175U true TWM559175U (en) 2018-05-01

Family

ID=62950613

Family Applications (1)

Application Number Title Priority Date Filing Date
TW106215844U TWM559175U (en) 2017-10-26 2017-10-26 Acacia gerberate capsule structure

Country Status (1)

Country Link
TW (1) TWM559175U (en)

Similar Documents

Publication Publication Date Title
JP5685540B2 (en) Chewable gelled emulsion
Zhao et al. Gastroretentive drug delivery systems for the treatment of Helicobacter pylori
AU2015211711B2 (en) Orally administered agent for ruminants and ruminant feed containing same
EA021063B1 (en) Composition for foodstuff for binding acetaldehyde and use thereof
Yang et al. Recent advances in complementary and replacement therapy with nutraceuticals in combating gastrointestinal illnesses
CN101129351A (en) Iron supplement composition, its preparing method and application of the same
JP2007169247A (en) Ginger-containing oral composition
JP2004018443A (en) Enteric capsule preparation
Pezzuto et al. Natural products for cancer chemoprevention
TWM559175U (en) Acacia gerberate capsule structure
CN104922160A (en) Composition prepared by compounding statin with Omega-3 fatty acid and coenzyme Q10 and application of composition
Krueger et al. Nutritional supplements and alternative medicine
CN107308358A (en) A kind of statin and the aliphatic acid of Omega 3 and vitamin complex composition
WO2011048388A2 (en) Oral pharmaceutical and nutraceutical compositions
JP2007014281A (en) Liquid food composition ingestible by spraying and method for producing the same
JPS59157018A (en) Novel oil-containing coated capsule pperaration
RU2129809C1 (en) Method for manufacturing food-stuff in capsules
CN108904807A (en) Melbine complex composition and its application
Marbaniang et al. Extended release floating microballoons containing Clerodendrum colebrookianum extract: In vitro in vivo evaluation
JP3240902U (en) Particle structure of lily extract that enhances skin moisture and improves skin wrinkles
TWM635025U (en) Capsule structure with acid resistance
CN104544051B (en) A kind of Capsules using bacillus acidophilus
WO2023018461A1 (en) Sleep product
JP2008069078A (en) Oxygen-containing soft capsule
Murata et al. Development of oral dissolving gelatin beads containing allopurinol for the prevention and treatment of mucositis